Stay updated on Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Sign up to get notified when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:34.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    - Revision history updated: v3.5.0 added; v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T22:51:16.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history and the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:25:27.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history and removed the older funding-lapse notice and Revision: v3.4.1; this is an administrative update with no effect on the study data.
    Difference
    0.5%
    Check dated 2026-02-11T02:07:29.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Notice about lapse in government funding added; page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-03T23:45:17.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle, green highlights for additions, red highlights for deletions, and visible revision labels (e.g., Revision: v3.4.0) to improve readability of changes.
    Difference
    0.7%
    Check dated 2026-01-28T00:32:06.000Z thumbnail image

Stay in the know with updates to Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.